XBI ETF

$140.72

Returns Overview

1 Month
+10.22%
3 Months
+16.19%
6 Months
+17.64%
YTD
+15.80%
1 Year
+73.31%
3 Years
+17.79%
5 Years
+1.45%
10 Years
+9.10%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would XBI have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+10.22%

3 Months Performance

+16.19%

6 Months Performance

+17.64%

1 Year Performance

+73.31%

Benchmark & Peers

Benchmark
S&P Biotechnology Select Industry Index(^SPSIBI:SP)
This ETF (YTD)
+15.80%
Peer Avg (YTD)
+1.69%
vs Peers
+14.11%

XBI ETF Performance

XBI performance across multiple time periods: 1-month 10.22%, YTD 15.80%, 1-year 73.31%, 3-year 17.79%, 5-year 1.45%, 10-year 9.10%.

XBI returns outperform the peer average of 1.69% YTD. With an expense ratio of 0.35%, investors should weigh costs against performance when evaluating this ETF.

XBI performance comparison shows side-by-side returns with another fund. XBI alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+10.22%May 18, 2026 to Jun 18, 2026
3 Months+16.19%Mar 18, 2026 to Jun 18, 2026
6 Months+17.64%Dec 18, 2025 to Jun 18, 2026
1 Year+73.31%N/A
3 Years+17.79%N/A
5 Years+1.45%N/A

All returns shown are total returns, not annualized